# Asher Biotherapeutics

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed September 3, 2026.

> Asher Biotherapeutics is pioneering cis-targeted immunotherapies that selectively activate specific immune cell types to achieve optimized efficacy and minimize toxicity, addressing shortcomings of conventional immunotherapies. Their lead molecule, etakafusp alfa (AB248), is a cis-targeted IL-2 designed for CD8+ effector T cells, showing initial evidence of anti-tumor activity.

- Business Profile: https://optimly.ai/brand/asher-biotherapeutics
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://asherbio.com/
- Logo: https://logo.clearbit.com/asherbio.com
- Slug: asher-biotherapeutics
- Brand Authority Index tier: Emerging
- Category: Oncology Immunotherapies
- Last Analyzed: September 3, 2026